PTGX
Price
$48.20
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
TRDA
Price
$17.37
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
7 days until earnings call
Ad is loading...

PTGX vs TRDA

Header iconPTGX vs TRDA Comparison
Open Charts PTGX vs TRDABanner chart's image
Protagonist Therapeutics
Price$48.20
Change-$0.00 (-0.00%)
Volume$356.2K
CapitalizationN/A
Entrada Therapeutics
Price$17.37
Change-$0.00 (-0.00%)
Volume$66.14K
CapitalizationN/A
View a ticker or compare two or three
PTGX vs TRDA Comparison Chart
Loading...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PTGX vs. TRDA commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTGX is a StrongBuy and TRDA is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (PTGX: $48.20 vs. TRDA: $17.37)
Brand notoriety: PTGX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTGX: 59% vs. TRDA: 49%
Market capitalization -- PTGX: $2.65B vs. TRDA: $594.45M
PTGX [@Biotechnology] is valued at $2.65B. TRDA’s [@Biotechnology] market capitalization is $594.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTGX’s FA Score shows that 2 FA rating(s) are green whileTRDA’s FA Score has 1 green FA rating(s).

  • PTGX’s FA Score: 2 green, 3 red.
  • TRDA’s FA Score: 1 green, 4 red.
According to our system of comparison, PTGX is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTGX’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • PTGX’s TA Score: 4 bullish, 3 bearish.
  • TRDA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than TRDA.

Price Growth

PTGX (@Biotechnology) experienced а +4.87% price change this week, while TRDA (@Biotechnology) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

PTGX is expected to report earnings on Mar 18, 2025.

TRDA is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($2.65B) has a higher market cap than TRDA($594M). PTGX has higher P/E ratio than TRDA: PTGX (16.54) vs TRDA (5.29). PTGX YTD gains are higher at: 110.205 vs. TRDA (15.109). PTGX has higher annual earnings (EBITDA): 156M vs. TRDA (96.9M). PTGX has more cash in the bank: 564M vs. TRDA (470M). PTGX has less debt than TRDA: PTGX (11M) vs TRDA (64.4M). PTGX has higher revenues than TRDA: PTGX (319M) vs TRDA (239M).
PTGXTRDAPTGX / TRDA
Capitalization2.65B594M446%
EBITDA156M96.9M161%
Gain YTD110.20515.109729%
P/E Ratio16.545.29313%
Revenue319M239M133%
Total Cash564M470M120%
Total Debt11M64.4M17%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
38
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTGXTRDA
RSI
ODDS (%)
Bearish Trend 7 days ago
64%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with VIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+1.99%
VIR - PTGX
43%
Loosely correlated
+3.61%
BEAM - PTGX
42%
Loosely correlated
+3.71%
CRNX - PTGX
42%
Loosely correlated
-1.40%
RCKT - PTGX
41%
Loosely correlated
+2.64%
RCUS - PTGX
41%
Loosely correlated
+2.08%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with AVIR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then AVIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+2.24%
AVIR - TRDA
39%
Loosely correlated
+2.39%
PLRX - TRDA
39%
Loosely correlated
+5.02%
INZY - TRDA
37%
Loosely correlated
-0.21%
RXRX - TRDA
36%
Loosely correlated
+6.02%
PTGX - TRDA
35%
Loosely correlated
+1.99%
More